DDrare: Database of Drug Development for Rare Diseases

Glucocorticoids - reduced dose (DrugBank: -)

2 diseases

ID	Disease name (Link within this page)	Number of trials
43	Microscopic polyangiitis	1
44	Wegener granulomatosis	1

43. Microscopic polyangiitis [ 85 clinical trials, 80 drugs, (DrugBank: 19 drugs), 13 drug target genes, 85 drug target pathways]

Searched query = "Microscopic polyangiitis", "MPA"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 85 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03919825 (ClinicalTrials.gov)	May 2010	15/4/2019	Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids	Plasma Exchange and Glucocorticoid Dosing in the Treatment of Anti-neutrophil Cytoplasm Antibody Associated Vasculitis: an International Randomized Controlled Trial [Glucocorticoids]	Granulomatosis With Polyangiitis (Wegener's) (GPA);Microscopic Polyangiitis (MPA)	Drug: Glucocorticoids - Standard Dose;Drug: Glucocorticoids - Reduced Dose	University of Pennsylvania	NULL	Completed	15 Years	N/A	All	704	Phase 3	NULL

44. Wegener granulomatosis [ 84 clinical trials, 88 drugs, (DrugBank: 22 drugs), 13 drug target genes, 37 drug target pathways]

Searched query = "Wegener granulomatosis", "Multiple vasculitis granulomatous disease", "Granulomatosis with polyangiitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 84 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03919825 (ClinicalTrials.gov)	May 2010	15/4/2019	Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids	Plasma Exchange and Glucocorticoid Dosing in the Treatment of Anti-neutrophil Cytoplasm Antibody Associated Vasculitis: an International Randomized Controlled Trial [Glucocorticoids]	Granulomatosis With Polyangiitis (Wegener's) (GPA);Microscopic Polyangiitis (MPA)	Drug: Glucocorticoids - Standard Dose;Drug: Glucocorticoids - Reduced Dose	University of Pennsylvania	NULL	Completed	15 Years	N/A	All	704	Phase 3	NULL